JNJ (Johnson & Johnson) Valuation Rank


JNJ Johnson & Johnson JNJ
85 GF Score
Price $255.34
GF Value $190.57
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Johnson & Johnson Valuation Rank Related Terms

JNJ
85GF Score
Johnson & Johnson JNJ
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Johnson & Johnson (JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $255.34 is trading 34% above its estimated GF Value™ of $190.57. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for JNJ:

  • Valuation Rank:
  • GF Value™: $190.57 vs. price of $255.34 (34% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for JNJ

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$255.34
Price
$190.57
GF Value